In8bio
Price & Volume
Stats
See more52W Range | $1.17-$7.86 |
Market Cap | $16.8M |
Shares Short | 146,831 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$5.26 |
News
See moreYahoo Finance • 25 days ago
IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer
Yahoo Finance • 4 months ago
IN8bio GAAP EPS of -$0.85 beats by $0.40
Yahoo Finance • 4 months ago
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
Yahoo Finance • 7 months ago
IN8bio GAAP EPS of -$1.24 beats by $0.56
About
CEO | Mr. Tai-Wei Ho |
CFO | Mr. Patrick McCall CPA |
Address | 350 5th Avenue, New York, NY, United States, 10118 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 17 |
